82 related articles for article (PubMed ID: 20450647)
1. [Risk stratification and target therapies in multiple myeloma].
Chen SL
Zhonghua Nei Ke Za Zhi; 2010 Mar; 49(3):195-7. PubMed ID: 20450647
[No Abstract] [Full Text] [Related]
2. Treatment of newly diagnosed multiple myeloma based on Mayo Stratification of Myeloma and Risk-adapted Therapy (mSMART): consensus statement.
Dispenzieri A; Rajkumar SV; Gertz MA; Fonseca R; Lacy MQ; Bergsagel PL; Kyle RA; Greipp PR; Witzig TE; Reeder CB; Lust JA; Russell SJ; Hayman SR; Roy V; Kumar S; Zeldenrust SR; Dalton RJ; Stewart AK
Mayo Clin Proc; 2007 Mar; 82(3):323-41. PubMed ID: 17352369
[TBL] [Abstract][Full Text] [Related]
3. Current clinical and laboratory strategies to augment the efficacy of immunotherapy in multiple myeloma.
Gorschlüter M; Ziske C; Glasmacher A; Schmidt-Wolf IG
Clin Cancer Res; 2001 Aug; 7(8):2195-204. PubMed ID: 11489792
[TBL] [Abstract][Full Text] [Related]
4. Prognostic and therapeutic significance of myeloma genetics and gene expression profiling.
Stewart AK; Fonseca R
J Clin Oncol; 2005 Sep; 23(26):6339-44. PubMed ID: 16155017
[TBL] [Abstract][Full Text] [Related]
5. Immune alterations in untreated and treated multiple myeloma.
Dasanu CA
J Oncol Pharm Pract; 2012 Jun; 18(2):257-63. PubMed ID: 21859744
[TBL] [Abstract][Full Text] [Related]
6. Multiple myeloma: new staging systems for diagnosis, prognosis and response evaluation.
Rajkumar SV; Buadi F
Best Pract Res Clin Haematol; 2007 Dec; 20(4):665-80. PubMed ID: 18070712
[TBL] [Abstract][Full Text] [Related]
7. Progress in multiple myeloma.
Jagannath S
Clin Lymphoma Myeloma; 2008 Aug; 8(4):202-4. PubMed ID: 18765306
[No Abstract] [Full Text] [Related]
8. Presentation and risk stratification--improving prognosis for patients with multiple myeloma.
Lonial S
Cancer Treat Rev; 2010 May; 36 Suppl 2():S12-7. PubMed ID: 20472183
[TBL] [Abstract][Full Text] [Related]
9. Review of molecular diagnostics in multiple myeloma.
Stewart AK; Fonseca R
Expert Rev Mol Diagn; 2007 Jul; 7(4):453-9. PubMed ID: 17620051
[TBL] [Abstract][Full Text] [Related]
10. Risk stratification in the era of novel therapies.
San-Miguel J; Mateos MV; Gutierrez NC
Cancer J; 2009; 15(6):457-64. PubMed ID: 20010164
[TBL] [Abstract][Full Text] [Related]
11. Multiple myeloma: new aspects of biology and treatment.
Ozaki S; Kosaka M
J Med Invest; 1998 Feb; 44(3-4):127-36. PubMed ID: 9597800
[TBL] [Abstract][Full Text] [Related]
12. Utilizing new biology to guide treatment directions in myeloma.
Morgan GJ
Clin Adv Hematol Oncol; 2013 Jan; 11(1):48-9. PubMed ID: 23416864
[No Abstract] [Full Text] [Related]
13. Gene mutation revelation points to new target for myeloma treatment, studies say.
Garber K
J Natl Cancer Inst; 2007 Sep; 99(18):1362-4. PubMed ID: 17848662
[No Abstract] [Full Text] [Related]
14. Autologous stem-cell transplantation for multiple myeloma.
Louw VJ; Louw H; Webb MJ
N Engl J Med; 2009 Sep; 361(11):1118-9; author reply 1119. PubMed ID: 19741236
[No Abstract] [Full Text] [Related]
15. [Molecular pathogenesis of myeloma for the therapeutic targets].
Hanamura I
Nihon Rinsho; 2007 Dec; 65(12):2202-8. PubMed ID: 18069261
[TBL] [Abstract][Full Text] [Related]
16. Advances in the biology and treatment of myeloma.
Morgan GJ
Br J Haematol; 1999 Apr; 105 Suppl 1():4-6. PubMed ID: 10330925
[No Abstract] [Full Text] [Related]
17. A practical guide to defining high-risk myeloma for clinical trials, patient counseling and choice of therapy.
Stewart AK; Bergsagel PL; Greipp PR; Dispenzieri A; Gertz MA; Hayman SR; Kumar S; Lacy MQ; Lust JA; Russell SJ; Witzig TE; Zeldenrust SR; Dingli D; Reeder CB; Roy V; Kyle RA; Rajkumar SV; Fonseca R
Leukemia; 2007 Mar; 21(3):529-34. PubMed ID: 17230230
[TBL] [Abstract][Full Text] [Related]
18. Synopsis of a roundtable on validating novel therapeutics for multiple myeloma.
Dalton W; Anderson KC
Clin Cancer Res; 2006 Nov; 12(22):6603-10. PubMed ID: 17121878
[TBL] [Abstract][Full Text] [Related]
19. Gene expression profiling in multiple myeloma--reporting of entities, risk, and targets in clinical routine.
Meissner T; Seckinger A; Rème T; Hielscher T; Möhler T; Neben K; Goldschmidt H; Klein B; Hose D
Clin Cancer Res; 2011 Dec; 17(23):7240-7. PubMed ID: 21986844
[TBL] [Abstract][Full Text] [Related]
20. New insights into the biology and advances in the management of multiple myeloma.
Harousseau JL
Best Pract Res Clin Haematol; 2007 Dec; 20(4):569-70. PubMed ID: 18070706
[No Abstract] [Full Text] [Related]
[Next] [New Search]
